Category: Life Sciences
Global Life Sciences
-
Multiple Sclerosis Drugs
... at a CAGR of 6.7% over the analysis period 2024-2030. Immmunomoderator Drugs, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$13.2 Billion by the end of ... Read More
-
Generic Drugs
... CAGR of 6.5% over the analysis period 2024-2030. Small-Molecule Generics, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$538.8 Billion by the end of the analysis ... Read More
-
Integrated Workplace Management Systems (IWMS)
... Billion by 2030, growing at a CAGR of 11.2% over the analysis period 2024-2030. Solutions, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$5.5 Billion by ... Read More
-
Label-Free Detection
... CAGR of 7.4% over the analysis period 2024-2030. Label-Free Detection Instruments, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$518.8 Million by the end of the ... Read More
-
Medical Device Reprocessing
... at a CAGR of 15.3% over the analysis period 2024-2030. Reprocessing Support & Services, one of the segments analyzed in the report, is expected to record a 14.2% CAGR and reach US$3.7 Billion by the ... Read More
-
Medical Animation
... CAGR of 15.2% over the analysis period 2024-2030. 4D, one of the segments analyzed in the report, is expected to record a 17.3% CAGR and reach US$428.1 Million by the end of the analysis period. ... Read More
-
Portable Ultrasound Equipment
... at a CAGR of 5.9% over the analysis period 2024-2030. Cart / Trolley-Based, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$2.4 Billion by the end ... Read More
-
Smart Hospitals
... CAGR of 22.9% over the analysis period 2024-2030. Services, one of the segments analyzed in the report, is expected to record a 21.8% CAGR and reach US$151.9 Billion by the end of the analysis period. ... Read More
-
Soldier Systems
... CAGR of 4.8% over the analysis period 2024-2030. Personal Protection, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$3.8 Billion by the end of the analysis ... Read More
-
Stem Cell Banking
... at a CAGR of 7.5% over the analysis period 2024-2030. Placental and Cord Blood Stem Cells, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$10.5 Billion ... Read More
-
Vendor Neutral Archive (VNA) and PACS
... reach US$6.5 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. PACS, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$4.4 ... Read More
-
Ophthalmic Ultrasound Systems
... at a CAGR of 3.9% over the analysis period 2024-2030. Portable, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$2.4 Billion by the end of the ... Read More
-
Pharmaceutical Hot Melt Extrusion Equipment
... Million by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Twin Screw Extruders, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$28.0 ... Read More
-
Physiotherapy Devices
... CAGR of 4.9% over the analysis period 2024-2030. Equipment, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$2.2 Billion by the end of the analysis period. ... Read More
-
Soft Tissue Allografts
... at a CAGR of 4.9% over the analysis period 2024-2030. Orthopedic, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.9 Billion by the end of the ... Read More
-
Spinal Fusion Devices
... at a CAGR of 3.4% over the analysis period 2024-2030. Thoracolumbar Devices, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$5.8 Billion by the end of ... Read More
-
Transcatheter Embolization and Occlusion Devices
... Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Embolization Coils, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$2.8 Billion ... Read More
-
N95 Masks
... CAGR of 12.2% over the analysis period 2024-2030. Offline, one of the segments analyzed in the report, is expected to record a 11.4% CAGR and reach US$13.5 Billion by the end of the analysis period. ... Read More
-
Sinuscopes
... 6.0% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$143.7 Million by the end of the analysis period. Growth in ... Read More
-
Aesthetic Implants
... CAGR of 5.5% over the analysis period 2024-2030. Breast Implants, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$4.9 Billion by the end of the analysis ... Read More
-
Manual Filling Equipment
... at a CAGR of 6.7% over the analysis period 2024-2030. Food & Beverages, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.1 Billion by the end ... Read More
-
Transcatheter Heart Valves
... at a CAGR of 16.6% over the analysis period 2024-2030. Transcatheter Aortic Valve (TAV), one of the segments analyzed in the report, is expected to record a 16.9% CAGR and reach US$31.4 Billion by the ... Read More
-
Restorative Dentistry
... CAGR of 8.5% over the analysis period 2024-2030. Restorative Materials, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$19.4 Billion by the end of the analysis ... Read More
-
Urinary Catheters
... CAGR of 6.1% over the analysis period 2024-2030. Intermittent Catheters, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$5.3 Billion by the end of the analysis ... Read More
-
Condoms
... 5.8% over the analysis period 2024-2030. Natural, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$9.2 Billion by the end of the analysis period. Growth in ... Read More
Research Assistance
